Millennium Laboratories to Host Medication Monitoring Symposium at PAINWeek 2013

Share Article

Symposium Offers Evidence to Aid in Enhanced Personalized Pain Care

PAINWeek 2013 invite front

WHAT: Millennium Laboratories, the leading research-based clinical diagnostic company dedicated to improving the lives of people suffering from pain and addiction, will host a lunch symposium* entitled: A Case-Based Exploration in Medication Management: Using PGT and UDT to Enhance Care at PAINWeek, the largest pain conference for pain management clinicians, in Las Vegas on Thursday Sept. 5.

        •Jennifer Strickland, PharmD, vice president of clinical strategy, Millennium Laboratories (moderator)

        •Chris Herndon, PharmD, BCPS, CPE, Southern Illinois University School of Pharmacy, Ill.

        •Eric Ehlenberger, MD, Accurate Clinic, La.

        •Jeremy Adler, MS, PA-C, Pacific Pain Medicine Consultants, Calif.

Representatives from Millennium Laboratories will be available on site for media interviews. For more information, please visit Millennium Laboratories at booth #113.

WHY: The treatment of pain is complex and challenging, and often incorporates multiple medications and modalities. Clinical tools such as urine drug testing (UDT) and pharmacogenetic testing (PGT) offer objective information that aids in a more personalized approach to care. This educational opportunity provides health care professionals with evidence emphasizing the clinical value of integrating pharmacogenetic testing (PGT) with urine drug testing (UDT) to enhance personalized pain care.

Millennium PGT is a saliva-based test designed to detect variations in enzymes associated with the metabolism of commonly prescribed medications. This tool can help clinicians personalize treatment and predict a patient’s genetically-driven response to certain medications. Millennium UDT utilizes Millennium’s proprietary methodologies and Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) technology to detect the presence of more than 375 brand name drugs from more than 80 parent drugs and metabolites. This highly specific and sensitive technology provides health care professionals with a quantitative measurement that is unaffected by other drugs or dietary supplements that may be present in the patient’s specimen.

WHO SHOULD ATTEND: Attendance is limited and available on a first come first served basis. Registered PAINWeek attendees may attend. Badge is required for entry.

WHEN: Thursday, September 5, 12:30-2:00 p.m.

WHERE: The Cosmopolitan of Las Vegas Brera Ballroom, 3708 S. Las Vegas Blvd., Las Vegas, NV 89109. PAINWeek attendee badge is required for entry.

*This program does not offer CME/CE credit. This satellite symposium is neither sponsored nor endorsed by PAINWeek.

Nicole Beckstrand
Corporate Communications
Millennium Laboratories


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Nicole Beckstrand
Visit website